A detailed history of Swiss National Bank transactions in Merck & Co., Inc. stock. As of the latest transaction made, Swiss National Bank holds 7,517,951 shares of MRK stock, worth $739 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
7,517,951
Previous 7,498,551 0.26%
Holding current value
$739 Million
Previous $928 Million 8.03%
% of portfolio
0.57%
Previous 0.65%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$111.15 - $128.97 $2.16 Million - $2.5 Million
19,400 Added 0.26%
7,517,951 $854 Million
Q2 2024

Aug 08, 2024

SELL
$123.8 - $132.96 $11.2 Million - $12 Million
-90,200 Reduced 1.19%
7,498,551 $928 Million
Q1 2024

May 07, 2024

SELL
$113.24 - $131.95 $39.2 Million - $45.6 Million
-345,900 Reduced 4.36%
7,588,751 $1 Billion
Q4 2023

Feb 06, 2024

SELL
$100.18 - $109.02 $22.7 Million - $24.7 Million
-227,000 Reduced 2.78%
7,934,651 $865 Million
Q3 2023

Nov 08, 2023

SELL
$102.95 - $114.33 $103 Million - $115 Million
-1,003,600 Reduced 10.95%
8,161,651 $840 Million
Q2 2023

Aug 09, 2023

SELL
$108.61 - $118.38 $97.4 Million - $106 Million
-896,700 Reduced 8.91%
9,165,251 $1.06 Billion
Q1 2023

May 10, 2023

SELL
$102.94 - $114.86 $24.1 Million - $26.9 Million
-234,000 Reduced 2.27%
10,061,951 $1.07 Billion
Q4 2022

Feb 08, 2023

SELL
$87.44 - $112.11 $58 Million - $74.4 Million
-663,281 Reduced 6.05%
10,295,951 $1.14 Billion
Q3 2022

Nov 09, 2022

SELL
$84.53 - $94.96 $481,821 - $541,272
-5,700 Reduced 0.05%
10,959,232 $944 Million
Q2 2022

Aug 09, 2022

BUY
$83.49 - $94.64 $2.04 Million - $2.31 Million
24,400 Added 0.22%
10,964,932 $1 Billion
Q1 2022

May 09, 2022

BUY
$73.51 - $82.4 $97 Million - $109 Million
1,318,900 Added 13.71%
10,940,532 $898 Million
Q4 2021

Feb 08, 2022

SELL
$72.28 - $90.54 $28.2 Million - $35.3 Million
-390,400 Reduced 3.9%
9,621,632 $737 Million
Q3 2021

Nov 08, 2021

SELL
$71.68 - $78.83 $21.9 Million - $24.1 Million
-305,600 Reduced 2.96%
10,012,032 $752 Million
Q2 2021

Aug 06, 2021

SELL
$70.31 - $77.77 $30.2 Million - $33.4 Million
-429,225 Reduced 3.99%
10,317,632 $802 Million
Q1 2021

May 07, 2021

BUY
$68.86 - $81.11 $13.1 Million - $15.4 Million
190,400 Added 1.8%
10,746,857 $828 Million
Q4 2020

Feb 05, 2021

SELL
$71.77 - $79.65 $495,213 - $549,585
-6,900 Reduced 0.07%
10,556,457 $864 Million
Q3 2020

Nov 09, 2020

SELL
$73.18 - $82.95 $15.1 Million - $17.1 Million
-205,800 Reduced 1.91%
10,563,357 $876 Million
Q2 2020

Aug 05, 2020

BUY
$70.42 - $80.13 $7.7 Million - $8.76 Million
109,300 Added 1.03%
10,769,157 $833 Million
Q1 2020

May 08, 2020

BUY
$63.36 - $87.82 $120 Million - $167 Million
1,900,600 Added 21.7%
10,659,857 $820 Million
Q4 2019

Feb 06, 2020

SELL
$77.58 - $87.54 $32.4 Million - $36.6 Million
-417,600 Reduced 4.55%
8,759,257 $797 Million
Q3 2019

Nov 12, 2019

BUY
$76.08 - $82.93 $3.81 Million - $4.15 Million
50,056 Added 0.55%
9,176,857 $773 Million
Q2 2019

Aug 02, 2019

SELL
$69.84 - $81.59 $19.8 Million - $23.1 Million
-283,600 Reduced 3.01%
9,126,801 $765 Million
Q1 2019

May 10, 2019

BUY
$69.58 - $79.36 $3.79 Million - $4.32 Million
54,400 Added 0.58%
9,410,401 $783 Million
Q4 2018

Feb 13, 2019

BUY
$65.24 - $75.71 $2.75 Million - $3.19 Million
42,200 Added 0.45%
9,356,001 $715 Million
Q3 2018

Nov 08, 2018

SELL
$57.69 - $67.84 $20.1 Million - $23.6 Million
-348,100 Reduced 3.6%
9,313,801 $661 Million
Q2 2018

Aug 09, 2018

BUY
$50.83 - $59.72 $9.05 Million - $10.6 Million
178,100 Added 1.88%
9,661,901 $586 Million
Q1 2018

May 04, 2018

SELL
$50.96 - $59.23 $62.8 Million - $73 Million
-1,232,400 Reduced 11.5%
9,483,801 $517 Million
Q4 2017

Feb 07, 2018

SELL
$51.62 - $61.64 $753,652 - $899,944
-14,600 Reduced 0.14%
10,716,201 $603 Million
Q3 2017

Nov 03, 2017

BUY
$58.67 - $63.13 $630 Million - $677 Million
10,730,801
10,730,801 $687 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $249B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.